APOLLOMICS INC Financials
This page shows APOLLOMICS INC (APLM) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 5 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
APOLLOMICS INC passes 1 of 9 financial strength tests. 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), neither operating efficiency signal passes.
For every $1 of reported earnings, APOLLOMICS INC generates $0.53 in operating cash flow (-$28.7M OCF vs -$53.9M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.
Key Financial Metrics
Earnings & Revenue
APOLLOMICS INC generated $0 in revenue in fiscal year 2024.
APOLLOMICS INC reported -$53.9M in net income in fiscal year 2024. This represents an increase of 68.8% from the prior year.
Cash & Balance Sheet
APOLLOMICS INC generated -$28.8M in free cash flow in fiscal year 2024, representing cash available after capex. This represents an increase of 33.4% from the prior year.
APOLLOMICS INC held $9.8M in cash against $733K in long-term debt as of fiscal year 2024.
Margins & Returns
APOLLOMICS INC's ROE was -1107.3% in fiscal year 2024, measuring profit generated per dollar of shareholder equity. This is down 688.7 percentage points from the prior year.
Capital Allocation
APOLLOMICS INC invested $24K in capex in fiscal year 2024, funding long-term assets and infrastructure. This represents an increase of 300.0% from the prior year.
APLM Income Statement
| Metric | Q4'24 | Q2'24 | Q4'23 | Q2'23 | Q4'22 | Q4'21 |
|---|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | N/A | N/A |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Income | N/A | N/A | N/A | N/A | N/A | N/A |
| Interest Expense | N/A | N/A | N/A | N/A | N/A | N/A |
| Income Tax | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS (Diluted) | N/A | N/A | N/A | N/A | N/A | N/A |
APLM Balance Sheet
| Metric | Q4'24 | Q2'24 | Q4'23 | Q2'23 | Q4'22 | Q4'21 |
|---|---|---|---|---|---|---|
| Total Assets | $13.1M-62.1% | $34.6M-37.6% | $55.4M-22.4% | $71.4M-6.7% | $76.5M-38.0% | $123.4M |
| Current Assets | $10.3M-63.9% | $28.4M-28.8% | $39.9M-27.9% | $55.4M-0.7% | $55.8M-43.9% | $99.4M |
| Cash & Equivalents | $9.8M-62.3% | $25.9M-19.1% | $32.1M+26.7% | $25.3M-22.6% | $32.7M-30.1% | $46.7M |
| Inventory | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Receivable | N/A | N/A | N/A | N/A | N/A | N/A |
| Goodwill | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $8.2M-40.2% | $13.8M-2.7% | $14.2M-9.7% | $15.7M-97.0% | $524.6M+56.0% | $336.3M |
| Current Liabilities | $7.4M-41.5% | $12.6M-6.7% | $13.6M-4.1% | $14.1M+14.4% | $12.4M-8.8% | $13.6M |
| Long-Term Debt | $733K-22.9% | $951K+256.2% | $267K-9.2% | $294K-22.0% | $377K-28.6% | $528K |
| Total Equity | $4.9M-76.6% | $20.8M-49.5% | $41.2M-26.0% | $55.7M+112.4% | -$448.1M-110.5% | -$212.9M |
| Retained Earnings | -$700.8M-2.7% | -$682.2M-5.4% | -$647.0M-3.5% | -$625.1M-31.7% | -$474.6M-101.6% | -$235.4M |
APLM Cash Flow Statement
| Metric | Q4'24 | Q2'24 | Q4'23 | Q2'23 | Q4'22 | Q4'21 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A |
| Investing Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A |
| Financing Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A |
APLM Financial Ratios
| Metric | Q4'24 | Q2'24 | Q4'23 | Q2'23 | Q4'22 | Q4'21 |
|---|---|---|---|---|---|---|
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Margin | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets | N/A | N/A | N/A | N/A | N/A | N/A |
| Current Ratio | 1.39-0.9 | 2.25-0.7 | 2.95-1.0 | 3.92-0.6 | 4.51-2.8 | 7.33 |
| Debt-to-Equity | 0.15+0.1 | 0.05+0.0 | 0.010.0 | 0.010.0 | -0.000.0 | -0.00 |
| FCF Margin | N/A | N/A | N/A | N/A | N/A | N/A |
Similar Companies
Frequently Asked Questions
What is APOLLOMICS INC's annual revenue?
APOLLOMICS INC (APLM) reported $0 in total revenue for fiscal year 2024. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
Is APOLLOMICS INC profitable?
No, APOLLOMICS INC (APLM) reported a net income of -$53.9M in fiscal year 2024.
How much debt does APOLLOMICS INC have?
As of fiscal year 2024, APOLLOMICS INC (APLM) had $9.8M in cash and equivalents against $733K in long-term debt.
What is APOLLOMICS INC's return on equity (ROE)?
APOLLOMICS INC (APLM) has a return on equity of -1107.3% for fiscal year 2024, measuring how efficiently the company generates profit from shareholder equity.
What is APOLLOMICS INC's free cash flow?
APOLLOMICS INC (APLM) generated -$28.8M in free cash flow during fiscal year 2024. This represents a 33.4% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is APOLLOMICS INC's operating cash flow?
APOLLOMICS INC (APLM) generated -$28.7M in operating cash flow during fiscal year 2024, representing cash generated from core business activities.
What are APOLLOMICS INC's total assets?
APOLLOMICS INC (APLM) had $13.1M in total assets as of fiscal year 2024, including both current and long-term assets.
What are APOLLOMICS INC's capital expenditures?
APOLLOMICS INC (APLM) invested $24K in capital expenditures during fiscal year 2024, funding long-term assets and infrastructure.
What is APOLLOMICS INC's current ratio?
APOLLOMICS INC (APLM) had a current ratio of 1.39 as of fiscal year 2024, which is considered adequate.
What is APOLLOMICS INC's debt-to-equity ratio?
APOLLOMICS INC (APLM) had a debt-to-equity ratio of 0.15 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is APOLLOMICS INC's return on assets (ROA)?
APOLLOMICS INC (APLM) had a return on assets of -411.2% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.
What is APOLLOMICS INC's cash runway?
Based on fiscal year 2024 data, APOLLOMICS INC (APLM) had $9.8M in cash against an annual operating cash burn of $28.7M. This gives an estimated cash runway of approximately 4 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
What is APOLLOMICS INC's Piotroski F-Score?
APOLLOMICS INC (APLM) has a Piotroski F-Score of 1 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are APOLLOMICS INC's earnings high quality?
APOLLOMICS INC (APLM) has an earnings quality ratio of 0.53x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.